Gumilid, Baby Girl .
HRN: 24-67-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
03/13/2024
03/19/2024
IVT
14mg
Q24
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes